PCR London Valves 2019

Other valvular and structural interventions Tricuspid / Pulmonary valve Mitral valve replacement and repair

Mitral and tricuspid transcatheter valves therapies: time to innovate!

Sponsored by Abbott

Chairpersons: G. Nickenig, S. Windecker

Panellists: J. Hausleiter, S. Kar, E. Lubos, P. Lurz, P. Sorajja, R. S. Von Bardeleben

SHOW MORE

Summary

Consult this session on mitral and tricuspid transcatheter valves therapies to learn all about the recent innovations and clinical evidences, and discover the Tendyne Clinical Program, a new transcatheter treatment option that eliminates mitral regurgitation.

Learning Objectives

To get up to date on MitraClip therapy's recent clinical evidences and innovation
To learn about tricuspid regurgitation and transcatheter therapies
To review the Tendyne Clinical Program and learn of a new therapy in high surgical risk patients in whom good repair results are unlikely

Prof. Stefan Windecker

Speaker

MitraClip therapy: from symptomatic to outcome benefit

Download presentation

S. Von Bardeleben

Speaker

R. S. Von Bardeleben

Device enhancement expands treatment options

Download presentation

Speaker

Glimpse into MitraClip’s future

Download presentation

Jorg Hausleiter

Speaker

Why should we treat tricuspid regurgitation using a transcatheter approach?

Download presentation

Speaker

What Triluminate tells us

Download presentation

Speaker

Tendyne, a new transcatheter treatment option that eliminates mitral regurgitation - Clinical programme update

Download presentation

Speaker

Transcatheter mitral valve implantation with the Tendyne system in patients with prior aortic valve replacement

Download presentation